Skip to content
value.today

Adimab, Inc.

🇺🇸 Lebanon, New Hampshire, USABiotechnologyFounded 2007
Total raised
$12 M
2 rounds on record
Latest round
$4 M
Nov 2010
First round on record
Sep 2009
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Adimab, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2010$4 MNo. 2$2 to $10 million

Adimab, Inc.: Raise no. 2, Nov 2010

Investors in this round

10 investors had bought by the notice of Nov 29, 2010: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Errik B. Anderson · Executive Officer
  • Robert L. Birnbaum · Executive Officer
  • Tillman U. Gerngross · Executive Officer, Director
  • Michael L. Ross · Director
  • Terrance L. McGuire · Director
  • William J. Maris · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert L. Birnbaum, Secretary. Source: SEC Form D, newest notice filed Nov 29, 2010. Read the notice at the SEC.

equitySEC
Sep 2009$8 MNo. 1$2 to $10 million

Adimab, Inc.: Raise no. 1, Sep 2009

Investors in this round

10 investors had bought by the notice of Oct 6, 2009: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
$633
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Errik B. Anderson · Executive Officer
  • Robert L. Birnbaum · Executive Officer
  • Tillman U. Gerngross · Executive Officer, Director
  • Bill L. Maris · Director
  • Michael L. Ross · Director
  • Terrance L. McGuire · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert L. Birnbaum, Secretary. Source: SEC Form D, newest notice filed Oct 6, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Adimab, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2010).

    SEC Form D · Nov 2010

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Nov 2010

That is all the official record says: Adimab, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Adimab, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Adimab, Inc.
NameRoleNamed in
Errik B. AndersonExecutive officerNov 2010
Robert L. BirnbaumExecutive officerNov 2010
Tillman U. GerngrossExecutive officerNov 2010
Michael L. RossDirectorNov 2010
Terrance L. McGuireDirectorNov 2010
Tillman U. GerngrossDirectorNov 2010
William J. MarisDirectorNov 2010
Bill L. MarisDirectorOct 2009